Voloridge Investment Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-12,789
| Closed | -$729K | – | 1552 |
|
|
2022
Q2 | $729K | Buy |
12,789
+11,752
| +1,133% | +$670K | ﹤0.01% | 1258 |
|
|
2022
Q1 | $84K | Buy |
+1,037
| New | +$84K | ﹤0.01% | 1316 |
|
|
2021
Q1 | – | Sell |
-17,042
| Closed | -$4.35M | – | 1570 |
|
|
2020
Q4 | $4.35M | Buy |
17,042
+5,386
| +46% | +$1.37M | 0.04% | 493 |
|
|
2020
Q3 | $2.9M | Buy |
11,656
+9,767
| +517% | +$2.43M | 0.02% | 598 |
|
|
2020
Q2 | $656K | Buy |
+1,889
| New | +$656K | 0.01% | 965 |
|
|
2019
Q4 | – | Sell |
-9,965
| Closed | -$2.72M | – | 1269 |
|
|
2019
Q3 | $2.72M | Buy |
9,965
+3,813
| +62% | +$1.04M | 0.05% | 376 |
|
|
2019
Q2 | $3.28M | Buy |
+6,152
| New | +$3.28M | 0.09% | 232 |
|
|
2019
Q1 | – | Sell |
-21,576
| Closed | -$10.6M | – | 1022 |
|
|
2018
Q4 | $10.6M | Buy |
+21,576
| New | +$10.6M | 0.48% | 53 |
|
|
2018
Q2 | – | Sell |
-153
| Closed | -$244K | – | 541 |
|
|
2018
Q1 | $244K | Sell |
153
-10,151
| -99% | -$16.2M | 0.01% | 460 |
|
|
2017
Q4 | $9.23M | Buy |
+10,304
| New | +$9.23M | 0.2% | 125 |
|